Objective-The goal of this study was to determine the role of Cdc42 in embryonic vasculogenesis and the underlying mechanisms. Key Words: angiogenesis Ⅲ endothelium Ⅲ signal transduction Ⅲ vascular biology V ascular morphogenesis takes place via 1 of 2 processes: vasculogenesis, in which progenitor cells differentiate into endothelial cells that construct a nascent vascular network; and angiogenesis, the formation of new blood vessels from existing vessels via sprouting and remodeling. Vasculogenesis mainly occurs during embryonic development, and the early blood vessels assemble from mesoderm-derived angioblasts, ancestors of vascular endothelial cells. Immunofluorescence studies using labeled antibodies that recognize endothelial cells and their progenitors have elucidated the following essential steps in embryonic vasculogenesis: (1) the derivation of angioblasts; (2) angioblast aggregation and formation of blood islands; (3) angioblast elongation and migration to form cord-like endothelial segments; (4) coalescence of endothelial segments into a continuous network; and (5) transformation of solid endothelial cords into vascular channels (lumen formation). 1 Vasculogenesis is guided by extracellular cues that include soluble growth factors, the extracellular matrix (ECM), and cell-cell interactions. Previous studies have established an essential role for growth factors and their receptors in endothelial cell differentiation, proliferation, and migration during vasculogenesis. For example, inactivation of the genes for vascular endothelial growth factor (VEGF) or its receptors Flk-1 and Flt-1 in mice causes severe defects in vasculogenesis and embryonic lethality. [2] [3] [4] Cell-cell and cell-ECM interactions are also important for vasculogenesis. Ablation of vascular endothelial (VE)-cadherin, a major endothelial cell adhesion receptor, induces apoptosis and the disassembly of nascent blood vessels. 5 Similarly, embryoid bodies (EBs) deficient for integrin ␤1, which pairs with a number of integrin ␣ subunits to form a large subfamily of heterodimeric ECM receptors, are defective in vascular assembly. 6 This is confirmed by endothelial-specific disruption of the integrin ␤1 gene in mice, which causes abnormal vascular development at embryonic day 8.5 and lethality at embryonic day 10.5. 7 Compared with these guidance cues for vasculogenesis, relatively less is known about the intracellular pathways that transmit these extracellular signals.
V ascular morphogenesis takes place via 1 of 2 processes: vasculogenesis, in which progenitor cells differentiate into endothelial cells that construct a nascent vascular network; and angiogenesis, the formation of new blood vessels from existing vessels via sprouting and remodeling. Vasculogenesis mainly occurs during embryonic development, and the early blood vessels assemble from mesoderm-derived angioblasts, ancestors of vascular endothelial cells. Immunofluorescence studies using labeled antibodies that recognize endothelial cells and their progenitors have elucidated the following essential steps in embryonic vasculogenesis: (1) the derivation of angioblasts; (2) angioblast aggregation and formation of blood islands; (3) angioblast elongation and migration to form cord-like endothelial segments; (4) coalescence of endothelial segments into a continuous network; and (5) transformation of solid endothelial cords into vascular channels (lumen formation). 1 Vasculogenesis is guided by extracellular cues that include soluble growth factors, the extracellular matrix (ECM), and cell-cell interactions. Previous studies have established an essential role for growth factors and their receptors in endothelial cell differentiation, proliferation, and migration during vasculogenesis. For example, inactivation of the genes for vascular endothelial growth factor (VEGF) or its receptors Flk-1 and Flt-1 in mice causes severe defects in vasculogenesis and embryonic lethality. [2] [3] [4] Cell-cell and cell-ECM interactions are also important for vasculogenesis. Ablation of vascular endothelial (VE)-cadherin, a major endothelial cell adhesion receptor, induces apoptosis and the disassembly of nascent blood vessels. 5 Similarly, embryoid bodies (EBs) deficient for integrin ␤1, which pairs with a number of integrin ␣ subunits to form a large subfamily of heterodimeric ECM receptors, are defective in vascular assembly. 6 This is confirmed by endothelial-specific disruption of the integrin ␤1 gene in mice, which causes abnormal vascular development at embryonic day 8.5 and lethality at embryonic day 10.5. 7 Compared with these guidance cues for vasculogenesis, relatively less is known about the intracellular pathways that transmit these extracellular signals.
Cdc42 is a small GTPase of the Rho family and is a key regulator of cell differentiation, migration, and the actin/ microtubule cytoskeleton. Like other members of the family, it cycles between a GTP-bound active form and a GDP-bound inactive form and acts as a molecular switch downstream of growth factor and ECM signaling. To date, a role for Cdc42 in embryonic vascular development has not been reported. Studies on Cdc42 in cultured endothelial cells have focused on its regulation of cytoskeletal organization, adherens junction assembly, and capillary lumen formation. 8 -11 Expression of constitutively active Cdc42 in porcine endothelial cells induced actin bundle formation and focal complex assembly. 12 Experiments using dominant-negative Cdc42 in mouse lung endothelial cells suggest that Cdc42 stabilizes adherens junctions and enhances the barrier function by inducing the interaction ␣-catenin with the cadherin complex. 9 Human umbilical vein endothelial cells cultured in collagen gel form intracellular vacuoles and lumens, and the green fluorescent protein (GFP)-Cdc42 fusion protein is targeted to the membrane of intracellular vacuoles. 11 Expression of a dominant-negative mutant or small interfering RNAmediated knockdown of Cdc42 blocks lumen formation. 11, 13 All these studies suggest that Cdc42 may be important for embryonic vasculogenesis.
In this study, we examined the role of Cdc42 in endothelial differentiation and vascular assembly using EBs derived from Cdc42 knockout embryonic stem (ES) cells. We showed that ablation of Cdc42 blocked vascular network assembly without affecting endothelial lineage differentiation. This phenotype was likely caused by impaired directional migration of endothelial cells. In addition, the activation of protein kinase C (PKC) was abolished in Cdc42-null endothelial cells. Targeted deletion of the PKC gene in EBs phenocopied the vasculogenetic defects of Cdc42-null EBs. These results suggest that Cdc42 is essential for embryonic vasculogenesis and that it controls vascular network assembly through PKC.
Methods

EB Culture and Vascular Differentiation
The ES cell lines used in this study were wild-type R1 ES cells, Cdc42 floxed (fl)/Ϫ and Ϫ/Ϫ ES cells, 14 and PKCϪ/Ϫ ES cells. 15 ES cell culture and EB differentiation have bee described previously. 16 To induce vasculogenesis, 5-day EBs were allowed to attach on Matrigel monomer (50 g/mL)-coated culture dishes or glass coverslips for 5 and 10 days, and the medium was changed every day.
Reagents
Growth factor-reduced Matrigel and monoclonal antibodies to platelet endothelial cell adhesion molecule (PECAM-1), VE-cadherin, ␤-catenin, Cdc42, and PKC were from BD Biosciences. Flk-1 polyclonal antibodies were from Santa Cruz Biotechnology. Glycogen synthase kinase-3␤ (GSK-3␤) and phospho-GSK-3␤ Ser9 polyclonal antibodies were from Cell Signaling Technology. Phospho-PKC (Thr555) polyclonal antibody was from Invitrogen. Myristoylated PKC pseudosubstrate (Myr-Ser-Ile-Tyr-Arg-ArgGly-Ala-Arg-Arg-Trp-Arg-Lys-Leu, which is 100% homologous to PKC) and VEGF 165 were from Sigma-Aldrich.
Magnetic Separation of Endothelial Cells From EB Cultures
EB cultures were digested with 1 mg/mL collagenase, 0.2 U/mL dispase, and 10 g/mL DNase I for 30 minutes at 37°C. Cells were washed twice with culture medium and incubated with rat anti-mouse PECAM-1 monoclonal antibody on ice for 40 minutes. The cells labeled with PECAM-1 monoclonal antibody were isolated with Dynabeads sheep anti-rat IgG (Invitrogen) according to the manufacturer's instructions. The beads bound cells were cultured in the microvascular endothelial cell medium (Lonza). Endothelial cell purity was Ͼ90% as assessed by positive immunostaining for Flk-1 and VE-cadherin.
Transfection of ES Cells and Endothelial Cells
Cdc42Ϫ/Ϫ ES cells were transfected with the vector expressing wild-type Cdc42 (Missouri S&T cDNA Resource Center) under the control of the mouse phosphoglycerate kinase promoter or the empty vector using Lipofectamine 2000 (Invitrogen). The PECAM-enhanced green fluorescence protein (EGFP) vector was obtained from Addgene and transfected into wild-type and Cdc42Ϫ/Ϫ ES cells. 17 Stable cell clones were established by G418 (500 g/mL) selection. ES clones overexpressing kinase-dead GSK-3␤ in the Cdc42-null background were as reported previously. 14 
Chimeric EB Culture
Wild-type ES cells stably transfected with PECAM-EGFP were mixed with Cdc42Ϫ/Ϫ ES cells in hanging drops at a 1:1 ratio and cultured for 1 day. Chimeric EBs formed in hanging drops were grown in suspension for 4 days and then allowed to attach on glass coverslips for 8 to 14 days. EBs were fixed and stained for GFP to identify wild-type endothelial cells and for PECAM-1 to identify both wild-type and Cdc42Ϫ/Ϫ endothelial cells.
Immunofluorescence
EBs and endothelial cells cultured on coverslips were fixed with 3% paraformaldehyde and immunostained for antigens of interest as described. 16 Slides were examined with a Nikon inverted microscope (Eclipse TE 2000), and digital images were acquired with a cooled charge-coupled device camera (Hamamatsu) controlled by IP Laboratory 4.0 software (Scanalytics). To quantify vascular assembly, digital images of PECAM-1 immunofluorescence were recorded in a consecutive fashion, and the number of vessel branch points per field was counted. Data were expressed as the meanϮSD unless indicated otherwise. The data were analyzed by Student t test or 1-way analysis of variance with Holm-Sidak comparisons in SigmaStat version 3.5 (Systat).
Immunoblotting
Attached EBs and cultured endothelial cells were lysed in SDS lysis buffer (50 mmol/L Tris, pH 7.4, 150 mmol/L NaCl, 1% SDS) containing protease and phosphatase inhibitor cocktails (Sigma). Immunoblotting was performed as previously described. 18 
Endothelial Cell Migration Assay
Endothelial cell migration was studied using both Transwell migration assay and time-lapse recording. For Transwell migration assay, Transwell culture inserts (polycarbonate, 6.5-mm diameter, and 8.0-m pore size, Corning) were coated with 10 g/mL Matrigel before addition of endothelial cells (30 000 cells/well) to the upper chamber. Cells were allowed to attach for 2 hours and then transferred to wells containing 30 nmol/L VEGF for an additional 4 hours. The inserts were fixed and stained with crystal violet. Cells remaining on the top of the filter were removed, and those that had migrated to the lower side were counted in 7 random fields for each insert.
Migration speed and tracks of endothelial cells were determined by digital time-lapse video microscopy as described. 18 Ambient temperature was maintained at 37°C using a temperature control cell (Tokai-Hit). Migration was monitored for 3 hours, the location of cell centroids at 10-minute intervals was tracked off-line, and migration speed was determined as the sum of interval distances divided by the total time.
Results
Cdc42 Is Required for Vascular Network Assembly
During murine embryogenesis, angioblasts arise from differentiation of mesoderm cells in the embryo proper and within the yolk sac, where they aggregate, elongate, and form primitive capillary plexuses. EBs differentiated from mouse ES cells is a tractable model for studying embryonic vasculogenesis. 19, 20 When cultured in suspension, normal ES cell aggregates formed spherical EBs with endoderm on their surface on day 2 (simple EBs) and developed into epithelial cysts by day 5 (cystic EBs), which consist of endoderm, an underlying basement membrane, and the epiblast epithelium enclosing a proamniotic-like cavity (Supplemental Figure IA , available online at http://atvb.ahajournals.org). When EBs attach to a hard surface, endoderm cells migrate out of EBs and are followed by the epiblast cells (Supplemental Figure  IB) , which give rise to blood vessels. Although capillary networks can arise from both simple and cystic EBs as revealed by PECAM-1 immunostaining, those generated from cystic EBs are more intricate and consistent (data not shown). Therefore, only cystic EBs were used to initiate vascular differentiation in this study.
To determine the role of Cdc42 in vascular development, we analyzed EBs cultured from wild-type, Cdc42 fl/Ϫ, and Ϫ/Ϫ ES cells. EB vasculogenesis from wild-type and Cdc42 fl/Ϫ ES cells are similar, and therefore the results obtained with either wild-type or Cdc42 fl/Ϫ ES cells are reported. When 5-day Cdc42 fl/Ϫ EBs attached to coverslips, endothelial cell aggregates formed by 5 days and a complex lattice of endothelial networks was evident by 10 days, as assessed by PECAM-1 and VE-cadherin staining ( Figure 1A ). Although Cdc42Ϫ/Ϫ EBs could also form PECAM-1-positive endothelial cell aggregates on day 5, they failed to construct a vascular network on day 10, although the number and size of the cell aggregates increased ( Figure 1A and 1B). Of note, VE-cadherin located at cell-cell junctions of Cdc42Ϫ/Ϫ endothelial cells, suggesting that VE-cadherin-mediated cellcell adhesions were not compromised. To confirm the vascular phenotype of Cdc42Ϫ/Ϫ EBs, we established stable ES cell lines expressing hemagglutinin-tagged wild-type Cdc42 in the Cdc42-null background ( Figure 1C ). PECAM-1 immunostaining of EBs differentiated on glass coverslips showed Figure 1 . Cdc42 ablation blocks vascular network assembly but not endothelial lineage differentiation. A, Five-day EBs were cultured on glass coverslips for 5 and 10 days and immunostained for platelet endothelial cell adhesion molecule (PECAM-1) and vascular endothelial (VE)-cadherin. Cdc42Ϫ/Ϫ EBs could form endothelial cell aggregates but failed to construct a vascular network. Arrowheads point to endothelial cell aggregates, and the arrow points to an elongated endothelial segment. B, Branch points of vascular networks were quantified and plotted. nϭ30 for each group. *PϽ0.01. C, Cdc42Ϫ/Ϫ EBs stably expressing hemagglutinin (HA)-tagged Cdc42 (HA-Cdc42) or the control vector (ctl) were cultured for 5 days and analyzed by immunoblotting for Cdc42. Wild-type (WT) EBs served as a positive control. D, Five-day Cdc42Ϫ/Ϫ EBs stably expressing HA-Cdc42 or the control vector were cultured on coverslips for 10 days and immunostained for PECAM-1. Expression of HA-Cdc42 largely rescued vascular network assembly. E, Vascular network formation was quantified and plotted. nϭ16 for each group. *PϽ0.01. F, Five-day EBs in adherent cultures for 10 days were analyzed by immunoblotting for Flk-1, PECAM-1, and VE-cadherin. Actin served as a loading control. G, The blots were analyzed by densitometry, and the ratio of the lineage markers to actin was plotted (nϭ7). H, Cdc42 floxed (fl)/Ϫ and Ϫ/Ϫ EBs cultured on coverslips were treated with 30 ng/mL VEGF for 10 days and then immunostained for PECAM-1. VEGF treatment failed to induce vascular network assembly in Cdc42Ϫ/Ϫ EBs.
that stable reexpression of Cdc42 in Cdc42-null EBs largely rescued vascular network assembly ( Figure 1D and 1E) , establishing an essential role for Cdc42 in EB vasculogenesis.
To test whether Cdc42 controls vascular network formation by promoting endothelial linage differentiation, we analyzed the expression of Flk-1, PECAM-1, and VEcadherin by immunoblotting. Cdc42 ablation did not significantly change the level of these endothelial cell lineage markers at 5, 7, or 10 days of EB differentiation ( Figure 1F and 1G and data not shown), nor did it change their location in endothelial cells ( Figure 1A ), indicating that Cdc42 is not required for endothelial linage differentiation.
VEGF is a major regulator of blood vessel formation. 21, 22 If the defective vascular network assembly results from decreased VEGF secretion, addition of exogenous VEGF should rescue the Cdc42Ϫ/Ϫ phenotype. To test this, we differentiated 5-day Cdc42 fl/Ϫ and Ϫ/Ϫ EBs on coverslips for 10 days in the presence of 30 ng/mL VEGF. VEGF treatment resulted in marked expansion and a denser vascular network in Cdc42 fl/Ϫ EBs ( Figure 1H ). However, despite the increased number of endothelial cell aggregates, no vascular network formed in Cdc42Ϫ/Ϫ EBs. These findings suggest that Cdc42 is likely to act downstream of VEGF to control vascular network assembly.
Another possibility is that Cdc42 ablation might increase cell-cell adhesions, impair their remolding, or both, thereby inhibiting endothelial cell migration and vascular network formation. To test this, we cultured EBs in the presence of 10 g/mL VE-cadherin neutralizing antibody to reduce adhesion strength between endothelial cells. Antibody treatment slightly reduced vascular network formation in Cdc42 fl/Ϫ EBs. By contrast, it dispersed Cdc42Ϫ/Ϫ endothelial cell aggregates into single cells (Supplemental Figure II) . The migration distance of Cdc42Ϫ/Ϫ endothelial cells was significantly increased (data not shown). However, the dispersed Cdc42Ϫ/Ϫ cells failed to assemble into networks. This result suggests that the vascular phenotype of Cdc42Ϫ/Ϫ EBs is unlikely to be caused by increased cell-cell adhesions.
Cdc42-Null Endothelial Cells Fail to Assemble Into Networks in Chimeric EB Cultures
To determine whether the defective vascular morphogenesis in Cdc42-null EBs is due to loss of Cdc42 in endothelial cells or in the surrounding cells, we performed chimeric analysis by mixing Cdc42Ϫ/Ϫ ES cells with wild-type ES cells stably transfected with GFP under the control of the mouse PECAM-1 promoter and enhancer (PECAM-EGFP). 17 The PECAM-EGFP ES cell colonies expressed low levels of GFP. GFP expression was also observed in 1-day EBs and disappeared thereafter during a 5-day period of suspension culture (data not shown).
Immunostaining of PECAM-EGFP EBs attached for 10 days revealed endothelial networks positive for both GFP and PECAM-1 (data not shown). When wild-type PECAM-EGFP ES cells were mixed with Cdc42Ϫ/Ϫ ES cells at a 1:1 ratio in hanging drops, they formed chimeric EBs (Figure 2A) . We cultured 5-day chimeric EBs on coverslips for 8 and 14 days. GFP and PECAM-1 doublepositive endothelial networks coexisted with endothelial cell aggregates/sheets stained only for PECAM-1 ( Figure  2B ). The GFP-negative and PECAM-1-positive cell aggregates (differentiated from Cdc42Ϫ/Ϫ ES cells) were often surrounded by endothelial networks positive for both GFP and PECAM-1 (differentiated from wild-type PECAM-EGFP ES cells). We did not observe any endothelial networks stained only for PECAM-1. These results suggest that failure of Cdc42Ϫ/Ϫ EBs to form vascular networks is likely caused by inactivation of Cdc42 in endothelial cells rather than surrounding cells.
Cdc42-Null Endothelial Cells Are Defective in Directional Migration and Network Assembly
To explore the mechanisms underlying the defective vascular morphogenesis in Cdc42Ϫ/Ϫ EBs, we isolated endothelial cells from attached EBs by magnetic sorting. The identity of endothelial cells was verified by immunostaining for Flk-1 and VE-cadherin ( Figure 3A and 3D and data not shown) . Endothelial cells isolated from wild-type EBs were very active in migration and formed multiple filopodia/lamellipodia. Cdc42 was targeted to the protruding edge of the cells ( Figure 4A ). To localize Cdc42 activation, we transfected normal endothelial cells with GFP-GBD, which specifically interacts with activated Cdc42. In contrast to GFP-transfected cells, GFP-GBD was concentrated at the protrusions of migrating cells ( Figure 4B ), suggesting that Cdc42 is activated at these locations.
To elucidate the role of Cdc42 in the migration of EBderived endothelial cells, we performed digital time lapse video microscopy and Transwell migration assay. Compared with the fl/Ϫ control, Cdc42Ϫ/Ϫ endothelial cells displayed defects in directional persistence and a reduced speed in migration ( Figure 4C ). Transwell migration assay revealed a reduction in VEGF-induced chemotaxis of the Cdc42Ϫ/Ϫ cells ( Figure 4D ). We further tested the ability of EB-derived endothelial cells to form networks on a thin layer of polymerized Matrigel, a process dependent on directional cell migration. Cdc42 fl/Ϫ endothelial cells assembled into capillary-like structures, whereas Cdc42Ϫ/Ϫ cells migrated randomly and could not form a network ( Figure 4E and 4F) . Altogether, these results suggest that loss of Cdc42 in endothelial cells impairs directional migration and thus vascular network assembly.
Endothelial Cells Use Lamellipodia Instead of Filopodia to Form Adherens Junctions in the Absence of Cdc42
Cdc42 is required for the formation of adherens junctions during epiblast epithelial morphogenesis and for the mainte- nance of junctional integrity in endothelial cells. 9, 14 We addressed whether Cdc42 might also regulate adherens junction formation in EB-derived endothelial cells. Immunostaining demonstrated that VE-cadherin was accumulated at cellcell junctions in both normal and Cdc42Ϫ/Ϫ endothelial cells ( Figure 3A and 3D) , suggesting that Cdc42 is dispensable for VE-cadherin-mediated cell-cell adhesions. Interestingly, in the normal cells, VE-cadherin and ␤-catenin were enriched in filopodia when cells made contact with each other ( Figure  3B ). These filopodia zipped up adjacent cells to form adherens junctions similar to those observed in dorsal closure in Drosophila ( Figure 3C ). 23 By contrast, very few filopodia were present in Cdc42Ϫ/Ϫ endothelial cells. Instead, VEcadherin and ␤-catenin were concentrated in lamellipodia in Cdc42Ϫ/Ϫ endothelial cells ( Figure 3E) , with extensive overlaps of the plasma membrane of adjacent cells during adherens junction assembly ( Figure 3F ). This result suggests that in the absence of Cdc42, Rac1-induced lamellipodia replaces Cdc42-dependent filopodia to deliver the VEcadherin-catenin complex to cell-cell junctions for adherent junction assembly.
PKC Is Activated by Cdc42 and Is Required for Vascular Network Assembly
Our previous study has suggested that atypical PKC (aPKC) is downstream of Cdc42 in mediating epithelial cell polarization. 14 aPKC has also been shown to be targeted to the leading edge of migrating astrocytes. 24 To test whether aPKC is activated by Cdc42 and mediates vascular network assembly, we first immunostained endothelial cells isolated from normal and Cdc42Ϫ/Ϫ EBs. Activated (phosphorylated at Thr555) PKC (pPKC), the major aPKC expressed in early mouse embryos, 25 was recruited to protrusions of normal endothelial cells similarly to activated Cdc42 (Figures 4B and 5A), but it was not detected in the periphery of Cdc42Ϫ/Ϫ endothelial cells. PKC formed a complex with Cdc42 in a coimmunoprecipitation assay ( Figure 5B ). Immunoblotting revealed that PKC phosphorylation was abolished in Cdc42Ϫ/Ϫ endothelial cells, although its expression levels were not affected ( Figure 5C ), suggesting that PKC is activated by Cdc42. To determine the role of PKC in vascular network assembly, we cultured 5-day normal and PKCϪ/Ϫ EBs on coverslips for 10 days. Similar to Cdc42Ϫ/Ϫ EBs, PKCϪ/Ϫ EBs could differentiate to form endothelial cell aggregates but not capillary networks ( Figure  5D and 5E). The expression of the endothelial lineage markers Flk-1, PECAM-1, and VE-cadherin was not significantly altered in the absence of PKC (Figure 5F and 5G). In addition, treatment of endothelial cells isolated from normal EBs with 50 mol/L myristoylated PKC/ pseudosubstrate blocked vascular assembly on Matrigel ( Figure 5H and 5I) . Altogether, these results suggest that PKC may act downstream of Cdc42 to mediate vascular network assembly.
GSK-3␤ Mediates Endothelial Segment Formation Downstream of Cdc42 and PKC
In migrating astrocytes, atypical PKC interacts with GSK-3␤ to polarize the centrosome. 26 To determine whether GSK-3␤ is a downstream effector of Cdc42 and PKC in vascular assembly, we first analyzed the spatial expression of GSK-3␤ in EBderived endothelial cells. Similar to activated Cdc42 and PKC, GSK-3␤ was observed at the protrusions of normal endothelial cells. However, it was detected mainly in the nucleus of the Cdc42Ϫ/Ϫ cells ( Figure 6A ). Next, we addressed whether GSK-3␤ activity is regulated by Cdc42. Immunoblots showed GSK-3␤ phosphorylation at Ser9 in Cdc42 fl/Ϫ but not in Ϫ/Ϫ endothelial cells, although its expression level did not change ( Figure 6B ). We also tested whether GSK-3␤ phosphorylation depends on PKC using a pseudosubstrate of aPKC. Treatment of normal endothelial cells with the aPKC inhibitor markedly reduced GSK-3␤ phosphorylation at Ser9 ( Figure 6C ). Phosphorylation of GSK-3␤ at serine 9 inhibits its catalytic activity. 27 In Cdc42Ϫ/Ϫ endothelial cells, pGSK-3␤ Ser9 is significantly Figure 5 . PKC is activated by Cdc42 and is required for vascular network assembly. A, Immunostaining showed that phospho-PKC T555 (pPKC) had accumulated at membrane protrusions of migrating normal endothelial cells (arrowheads), whereas it was not detected at the periphery of Cdc42Ϫ/Ϫ cells. The bottom panel shows a PKCϪ/Ϫ fibroblast stained for pPKC, demonstrating that the nuclear staining is nonspecific. B, Coimmunoprecipitation showed that Cdc42 formed a complex with PKC. C, Endothelial cells were analyzed by immunoblotting for pPKC and PKC. Actin served as a loading control. PKC activation was abolished in the absence of Cdc42. D, Five-day wild-type (WT) and PKCϪ/Ϫ EBs were cultured on coverslips for 10 days and immunostained for platelet endothelial cell adhesion molecule (PECAM)-1. PKC ablation blocked vascular network assembly. E, Vascular assembly was quantified and plotted. (nϭ23 for each group). *PϽ0.01. F, Five-day wild-type and PKCϪ/Ϫ EBs were differentiated in adherent cultures for 10 days and cell lysates were analyzed by immunoblotting for Flk-1, PECAM-1, and vascular endothelial (VE)-cadherin. G, The blots were analyzed by densitometry, and the ratio of the lineage markers to actin was plotted (nϭ4). H, Endothelial cells isolated from normal EBs were cultured on a thin layer of polymerized Matrigel in the presence or absence of 50 mol/L PKC/ inhibitor for 24 hours. Phase micrographs show the PKC/ pseudopeptide inhibited the assembly of capillary-like networks compared with the BSA control (ctl). I, Capillary-like network formation was quantified and plotted (nϭ21). *PϽ0.01.
reduced, indicating increased kinase activity of GSK-3␤. GSK-3␤ phosphorylates a number of microtubule-associated proteins and thereby destabilizes the microtubule cytoskeleton, the integrity of which is crucial for cell polarization. To determine whether increased kinase activity of GSK-3␤ in Cdc42Ϫ/Ϫ EBs inhibits vascular network formation, we stably overexpressed kinase-dead GSK-3␤ (GSK-3␤ KD) in Cdc42Ϫ/Ϫ ES cells and analyzed its effect on vascular assembly. The expression of GSK-3␤ KD in Cdc42Ϫ/Ϫ EBs promoted the formation of linear endothelial cell segments of various lengths. However, these endothelial cell segments failed to undergo branching morphogenesis and coalesce into a network ( Figure 6D ). These results suggest that GSK-3␤ mediates Cdc42-and PKC-dependent endothelial cell elongation and directional migration but not branching morphogenesis.
Discussion
Cdc42 is a well-known Rho GTPase and has been implicated in the regulation of cytoskeletal dynamics, migration, polarization, and differentiation in many cell types, including cultured endothelial cells. However, its role in embryonic vasculogenesis was unknown. In this study, we showed that Cdc42 is essential for vascular network assembly during EB vasculogenesis, although it is not required for endothelial lineage differentiation and VE-cadherin-mediated cell-cell adhesions. Furthermore, we demonstrated that PKC is activated downstream of Cdc42 in endothelial cells and its genetic ablation yields a vascular phenotype similar to that of Cdc42-deficient EBs. These findings suggest that Cdc42 controls vascular network assembly through PKC.
Role of Cdc42 in Vasculogenesis
RhoA, Rac1, and Cdc42 are the prototypical members of Rho GTPases. Most of our insights into their cellular functions are obtained from cell culture studies using dominant negative or constitutively active GTPases. However, gene targeting in mice has allowed specific inactivation of Rho GTPases of interest and subsequent analysis of their in vivo functions in a global or tissue-specific manner. Global or endothelialspecific deletion of the RhoA gene in mice has not been reported. Deletion of either Cdc42 or Rac1 in the zygote leads to early embryonic lethality, and mutant mice die at embryonic days 4.5 and 6.5, respectively, precluding the analysis of their roles in vascular development. 28, 29 Conditional knockout of Rac1 in endothelial cells results in embryonic lethality in midgestation because of defects in vasculogenesis. 30 The Rac1-deficient embryos are able to form the dorsal aorta but fail to develop small branching vessels. In addition, vascular development is completely absent in the mutant yolk sac. These results suggest Rac1 is required for endothelial lineage differentiation in the yolk sac and vascular branching morphogenesis in the embryo proper. This in vivo phenotype is in agreement with our findings in EB vasculogenesis from Rac1-defient ES cells, which demonstrate defects in endothelial lineage differentiation and branching morphogenesis (data not shown). By contrast, ablation of Cdc42 in ES cells does not affect endothelial lineage differentiation but completely blocks vascular network assembly. Unlike the Rac1-null endothelial cells, which display impaired spreading, focal adhesion formation, and actin stress fiber assembly on ECM substrates, 30 Cdc42-null endothelial cells are able to spread and form focal adhesions. In fact, the assembly of actin stress fibers is enhanced in the mutant cells (data not shown). However, directional persistence of endothelial cell migration, which relies on the stability of asymmetrical intracellular signaling, is lost in the absence of Cdc42. Furthermore, Cdc42-null endothelial cells fail to assemble into capillary-like networks on Matrigel, although they can migrate on this substrate. Our results suggest that the vasculogenetic defects of Cdc42-defient EBs are at least partly due to impaired directional migration of endothelial cells.
Downstream Effectors of Cdc42 That Mediate Vascular Network Assembly
Cdc42 is an ancient signaling protein, and its homologue is present in yeast, Caenorhabditis elegans, and Drosophila. Several effector pathways of Cdc42 are also conserved throughout the Metazoa. Among them, the Par6-Par3-aPKC complex plays a critical role in the establishment of cell polarity. 31, 32 Par6 contains a partial Cdc42-Rac interactive binding motif, which mediates the interaction with activated Cdc42. Par6 can also bind to aPKC and Par3 through PD1 and PDZ domain interactions, respectively. 33 The Par6-aPKC complex has been suggested to be essential for polarity establishment during directional migration of rat astrocytes. 24 In this study, we found that Cd42 coimmunoprecipitates with PKC and that GTP-bound Cdc42 is localized at the protrusions of migrating endothelial cells together with activated PKC, whose activation depends on Cdc42. Furthermore, ablation of PKC in EBs blocks vascular network assembly without affecting endothelial lineage differentiation, phenocopying Cdc42 deficient EBs. These results suggest that activated Cdc42 recruits and activates PKC at membrane protrusions; the latter is required for directional migration of endothelial cells and vascular network assembly. The novel PKC isoform and atypical PKC have been suggested to be involved in the lumen formation in endothelial cells cultured in collagen gel. 13 However, they are unlikely to play an important role in embryonic vasculogenesis because PKC and PKC knockout mice are fertile and have no vascular phenotype. 34, 35 Par6 likely mediates the recruitment of PKC by Cdc42 because it has been shown to form a complex with Cdc42 and aPKC in rat astrocytes and mouse keratinocytes. 24, 36 Therefore, it would be interesting to know whether targeted disruption of the Par6 gene or knockdown of its expression affects vasculogenesis.
The in vitro kinase assay demonstrates GSK-3␤ to be a PKC substrate. 37 In polarized rat astrocytes and Madin-Darby canine kidney cells, GSK-3␤ is a downstream effector of the Cdc42-Par6-PKC complex. 26 In this study, we show that GSK-3␤ is localized at the protrusions of migrating endothelial cells. GSK-3␤ phosphorylation at Ser9 is abolished in the absence of Cdc42 and is significantly reduced by treatment with aPKC pseudopeptide inhibitor. These results suggest that GSK-3␤ is a target of Cdc42 and PKC in endothelial cells. However, the expression of kinase-dead mutant GSK-3␤ in Cdc42-null ES cells fails to rescue branching morphogenesis during EB vasculogenesis, although it promotes the formation of linear endothelial segments. One explanation is that GSK-3␤ must be targeted to the leading edge of migrating cells to mediate vascular network assembly, and overexpression of kinase-dead GSK-3␤ in a diffuse fashion cannot fulfill the task. Another possibility is that effectors other than GSK-3␤ control vascular branching morphogenesis downstream of Cdc42 and PKC.
Cdc42 Activation During Vasculogenesis
Integrins of the ␤1 family are major ECM receptors expressed during embryonic development. 38 Studies on EB vasculogenesis using integrin ␤1-deficient ES cells have demonstrated that ␤1 integrins are required for the assembly of capillary-like networks. 6 A recent elegant study using VE-cadherin promoter-mediated inactivation of integrin ␤1 in mouse blood vessels has demonstrated that integrin ␤1 is required for polarizing endothelial cells and vascular lumen formation. 39 Similarly, our data showed that Cdc42 is also involved in the establishment of endothelial cell polarity, suggesting that integrin and Cdc42 may act in the same signaling pathway. In fact, we found that Cdc42 activation is inhibited in endothelial cells isolated from integrin ␤1-null EBs (data not shown). However, the guanine nucleotide exchange factor that activates Cdc42 downstream of integrin signaling remains unknown.
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